PCOS – Medxy AI

Enhanced Therapeutic Benefits of Combined Metformin and Curcumin in Women with Polycystic Ovary Syndrome: Results from a Factorial Clinical Trial

By MedXY 09/16/2025

A 12-week randomized trial demonstrates that combining metformin and nanocurcumin significantly improves lipid metabolism, glucose regulation, hormonal balance, and body metrics in women with PCOS, surpassing effects seen with either agent alone or placebo.

Clinical Updates Wellness & Lifestyle

Enhanced Therapeutic Outcomes in Overweight/Obese Women with PCOS: Combining Metformin and Semaglutide

By MedXY 09/16/2025

Combination therapy with metformin and semaglutide improves weight loss, metabolic parameters, menstrual function, and natural pregnancy rates in overweight/obese women with PCOS compared to metformin alone.

Wellness & Lifestyle

Gut Microbiota and Pregnancy Risks: the Connection in Polycystic Ovary Syndrome

By MedXY 07/29/2025

Scientific findings link imbalances in gut microbiota and metabolic markers to pregnancy complications in women with PCOS.

Wellness & Lifestyle

Exploring Sexual Function in Women with PCOS: Insights from Recent Research

By MedXY 07/28/2025

A systematic review assesses sexual function in women with PCOS, revealing impaired psychosexual function and calling for more diverse and comprehensive studies.

Wellness & Lifestyle

Navigating the Complex World of PCOS: A Gender-Diverse Perspective

By MedXY 07/28/2025

Exploring the unique experiences of gender-diverse individuals with PCOS and its impact on gender identity.

Wellness & Lifestyle

Understanding Idiopathic Hirsutism: A Misnomer in Medical Science?

By MedXY 07/28/2025

Idiopathic hirsutism, characterized by excessive hair growth, may not be truly idiopathic. Research suggests underlying androgen mechanisms could redefine its classification.